Taro Pharmaceutical Industries Ltd. logo

Taro Pharmaceutical Industries Ltd.

NYSE:TARO

Overview | Financials
Company Name Taro Pharmaceutical Industries Ltd.
Symbol TARO
Currency USD
Price 42.73
Market Cap 1,605,989,958
Dividend Yield 0%
52-week-range 32.67 - 45.76
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. Uday V. Baldota
Website https://www.taro.com

An error occurred while fetching data.

About Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic

Related Stocks

Arcus Biosciences, Inc. logo

Arcus Biosciences, Inc.

RCUS

15.81 USD

Avanos Medical, Inc. logo

Avanos Medical, Inc.

AVNS

20.18 USD

Paragon 28, Inc. logo

Paragon 28, Inc.

FNA

6.58 USD

U.S. Physical Therapy, Inc. logo

U.S. Physical Therapy, Inc.

USPH

95.08 USD

Nevro Corp. logo

Nevro Corp.

NVRO

9.45 USD

Cano Health, Inc. logo

Cano Health, Inc.

CANO

2.3 USD

Bright Health Group, Inc. logo

Bright Health Group, Inc.

BHG

16.35 USD

Pediatrix Medical Group, Inc. logo

Pediatrix Medical Group, Inc.

MD

7.1 USD

Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc.

EBS

6.32 USD

Financials

Numbers are in millions USD

Numbers are in millions USD